Dr. Sharon Agnes Levandowski MD
Hematologist-Oncologist | Hematology & Oncology
621 COURT ST WEST BRANCH MI, 48661About
Dr. Sharon Levandowski is a hematologist oncologist practicing in Grosse Pointe, MI. Dr. Levandowski specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Ross University School Of Medicine, Roseau, Commonwealth Of Dominica, West Indies MD
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Clinical Trials
Dr. Sharon Agnes Levandowski MD's Practice location
Dr. Sharon Agnes Levandowski MD's reviews
Write ReviewPatient Experience with Dr. Levandowski
Recommended Articles
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- This New Zealand Native Beat Cancer Eight Times
Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
- Multiple Myeloma: What is Autotransplantation?
During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial
When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...